| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forma Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 9.01M | $45.5M | $5.05 | 17 Jun 2021 | Indirect |
| Therapeutics Acquisition Corp. | Chief Executive Officer, Director | Common Stock | 1.1M | $13.7M | $12.45 | 29 Jun 2021 | Indirect |
| Forma Therapeutics Holdings, Inc. | Director, 10%+ Owner | Common Stock | 2.75K | $13.9K | $5.05 | 17 Jun 2021 | Direct |
| Forma Therapeutics Holdings, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 8.38K | 17 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PNT | Therapeutics Acquisition Corp. | 29 Jun 2021 | 1 | $2.09M | 4 | Chief Executive Officer, Director | 30 Jun 2021, 16:31 |
| PNT | Therapeutics Acquisition Corp. | 24 Jun 2021 | 1 | $8.89M | 4 | Chief Executive Officer, Director | 24 Jun 2021, 19:08 |
| FMTX | Forma Therapeutics Holdings, Inc. | 17 Jun 2021 | 2 | $0 | 4 | Director, 10%+ Owner | 21 Jun 2021, 19:01 |